Development of innovative therapeutic antibodies targeting the inflammatory tumor microenvironment in refractory thoracic tumors
Development of innovative therapeutic antibodies targeting the inflammatory tumor microenvironment in refractory thoracic tumors
批准号:
18K19581
负责人:
Toyooka Shinichi
金额:
$3.99万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
财政年份:
2018
资助国家:
日本
项目状态:
已结题
起止时间:
2018-06-29 至 2021-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Clinicopathological characteristics of lung cancer patients with concomitant idiopathic pulmonary fibrosis
肺癌合并特发性肺纤维化患者的临床病理特征
DOI:
--
发表时间:
2019
期刊:
影响因子:
--
作者:
[Kota Araki, Kazuhiko Shien, Shunsaku Miyauchi, Akihiro Miura, Yuta Takahashi, Eisuke Kurihara, Yusuke Ogoshi, Kei Namba, Ken Suzawa, Hiromasa Yamamoto, Shuta Tomida, Junichi Soh, Masakiyo Sakaguchi, Shinichi Toyooka]
通讯作者:
Shinichi Toyooka
Development of the novel therapy focused on damage-associated molecular patterns (DAMPs) for lung fibrosis-related diseases
-
批准号:19H03746
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2019
-
负责人:Toyooka Shinichi
-
依托单位:
Development of new therapeutic strategy based on gene expression and mutation profiles in EGFR mutant lung cancer
-
批准号:16H05431
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.23万
-
财政年份:2016
-
负责人:Toyooka Shinichi
-
依托单位:
New therapeutic strategy for non-small cell lung cancer by REIC gene therapy
-
批准号:26670627
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:Toyooka Shinichi
-
依托单位:
Understanding and overcoming drug resistance to EGFR-inhibitors for lung cancer
-
批准号:25293302
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.82万
-
财政年份:2013
-
负责人:Toyooka Shinichi
-
依托单位:
海外基金